A cursory glance at any financial newsfeed these days will definitively prove - SPACs are back. More relevant than telling us skinny jeans are out and mom jeans are in again, the tides of the IPO being the go-to route to NASDAQ have shifted.
Here’s the scoop on IPO versus SPAC (Special Purpose Acquisition Corporation) from Paul Mieyal, life sciences investment guru.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,